Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China.
National Engineering Research Center for R&D of TCM Multi-Ingredient Drugs, Beijing 100079, China.
Biomed Res Int. 2017;2017:3495021. doi: 10.1155/2017/3495021. Epub 2017 Sep 28.
Myocardial infarction (MI) patients are at high risk of potential lethal arrhythmia. Gap junction and microRNA-1 (miR-1) are both arrhythmia generating conditions. The present study investigated whether Wenxin Granules (Wenxin-Keli, WXKL) could prevent potential lethal arrhythmia by improving gap junctions and miR-1 following MI. Male Sprague-Dawley rats were divided randomly into control, model, metoprolol, low dose WXKL, and high dose WXKL groups. The MI rat model was created by coronary artery ligation. Treatments were administrated intragastrically to the rats for 4 weeks. Conventional transmission electron microscopy was performed to observe the ultrastructure of gap junctions. Quantitative real-time PCR and western blotting were used to detect the expression of miR-1, protein kinase C (PKC), and related proteins. Additionally, a programmatic electrophysiological stimulation test was performed to detect the ventricular fibrillation threshold (VFT). WXKL protected the ultrastructure of the gap junctions and their constituent Cx43 by regulating miR-1 and PKC mediated signal transduction and increased the VFT significantly in the rat MI model. The results suggested that WXKL is an effective alternative medicine to prevent potentially lethal arrhythmia following MI.
心肌梗死(MI)患者存在潜在致命性心律失常的高风险。缝隙连接和 microRNA-1(miR-1)都是产生心律失常的条件。本研究旨在探讨稳心颗粒(Wenxin-Keli,WXKL)是否可以通过改善 MI 后缝隙连接和 miR-1 来预防潜在致命性心律失常。雄性 Sprague-Dawley 大鼠随机分为对照组、模型组、美托洛尔组、低剂量 WXKL 组和高剂量 WXKL 组。通过冠状动脉结扎建立 MI 大鼠模型。将大鼠进行胃内给药治疗 4 周。采用常规透射电镜观察缝隙连接的超微结构。采用实时定量 PCR 和 Western blot 检测 miR-1、蛋白激酶 C(PKC)和相关蛋白的表达。此外,还进行了程控电生理刺激试验以检测心室颤动阈值(VFT)。WXKL 通过调节 miR-1 和 PKC 介导的信号转导保护缝隙连接及其组成 Cx43 的超微结构,并显著增加 MI 大鼠模型中的 VFT。结果表明,WXKL 是预防 MI 后潜在致命性心律失常的有效替代药物。